NNC0497-0040
/ Novo Nordisk
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 05, 2026
A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity
(clinicaltrials.gov)
- P1 | N=146 | Recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Recruiting
Enrollment open • Diabetes • Genetic Disorders • Metabolic Disorders • Obesity • Type 1 Diabetes Mellitus • Type 2 Diabetes Mellitus
May 12, 2026
A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity
(clinicaltrials.gov)
- P1 | N=146 | Not yet recruiting | Sponsor: Novo Nordisk A/S
New P1 trial • Diabetes • Genetic Disorders • Metabolic Disorders • Obesity • Type 1 Diabetes Mellitus • Type 2 Diabetes Mellitus
1 to 2
Of
2
Go to page
1